Gene: SMIM24
Official Full Name: small integral membrane protein 24provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05633 | SMIM24 Knockout cell line (HeLa) | Human | SMIM24 | 1:3~1:6 | Negative | Online Inquiry |
KO05634 | SMIM24 Knockout cell line (A549) | Human | SMIM24 | 1:3~1:4 | Negative | Online Inquiry |
SMIM24 Gene Knockout Cell Lines are advanced cellular models specifically engineered for the study of the small integral membrane protein 24 (SMIM24). This gene plays a significant role in cellular processes including membrane dynamics and protein trafficking, making it a crucial target for understanding various cellular functions and disease mechanisms. By utilizing CRISPR-Cas9 technology, these knockout cell lines exhibit a complete absence of SMIM24 expression, allowing researchers to investigate the downstream effects on cellular pathways and phenotypes without interference from the native protein.
The primary function of SMIM24 Gene Knockout Cell Lines is to facilitate the dissection of the biological role of the SMIM24 protein in both normal physiology and pathological conditions. Researchers can leverage these models to explore how the absence of SMIM24 affects cellular responses such as apoptosis, cell proliferation, and differentiation. Furthermore, these knockout lines are invaluable for drug screening and biomarker discovery, offering a platform to identify potential therapeutic targets in diseases where SMIM24 is implicated.
The scientific importance of these cell lines extends to both basic and translational research settings. Their ability to provide insight into the molecular mechanisms underlying various diseases, such as cancer and metabolic disorders, positions them as essential tools for both academic research and clinical applications.
One of the distinct advantages of the SMIM24 Gene Knockout Cell Lines is their high specificity and the ability to produce reproducible results. Unlike traditional knockout methods that can produce variable results or unintended off-target effects, our CRISPR-Cas9-derived lines ensure precise gene editing, reducing the likelihood of confounding factors in experimental outcomes. This contributes to more reliable data, which is fundamental for advancing research agendas and accelerating the path to clinical applications.
For researchers and clinicians, the value of SMIM24 Gene Knockout Cell Lines lies in their capacity to improve the understanding of SMIM24 function, unlocking new pathways for therapeutic intervention. With their robust performance characteristics and reliable gene disruption, these cell lines stand at the forefront of innovation in biological research.
Our company leverages extensive experience in gene editing technologies and cell line development, ensuring that our offerings maintain the highest standards of quality and efficacy. By choosing SMIM24 Gene Knockout Cell Lines, you are aligning with a partner committed to driving scientific discoveries that can positively impact health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.